(MTCH) Match - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US57667L1070
Stock: Online Dating, Social Networking, Mobile Apps
Total Rating 37
Risk 35
Buy Signal 0.05
| Risk 5d forecast | |
|---|---|
| Volatility | 35.0% |
| Relative Tail Risk | -10.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.00 |
| Alpha | -20.48 |
| Character TTM | |
|---|---|
| Beta | 0.885 |
| Beta Downside | 1.467 |
| Drawdowns 3y | |
|---|---|
| Max DD | 43.59% |
| CAGR/Max DD | -0.11 |
EPS (Earnings per Share)
Revenue
Description: MTCH Match March 04, 2026
Match Group Inc. (MTCH) provides digital technologies. The company operates in the online dating sector, a market characterized by network effects where the value of the service increases with the number of users.
MTCH segments its operations into Tinder, Hinge, Evergreen and Emerging, and Match Group Asia. This multi-brand strategy is common in consumer-facing digital services to target diverse user demographics and preferences.
The companys portfolio includes well-known dating apps such as Tinder, Hinge, and Match, among others. These services aim to facilitate user connections and are available globally in over 40 languages.
Match Group Inc. was incorporated in 1986 and is headquartered in Dallas, Texas. For more detailed financial analysis, consider exploring ValueRays comprehensive reports.
Headlines to watch out for
- Tinder subscriber growth impacts overall revenue
- Hinge expansion drives international market penetration
- Regulatory scrutiny on data privacy increases compliance costs
- Advertising spending directly influences user acquisition rates
- Macroeconomic conditions affect discretionary consumer spending
Piotroski VR‑10 (Strict, 0-10) 9.0
| Net Income: 613.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.23 > 0.02 and ΔFCF/TA 3.19 > 1.0 |
| NWC/Revenue: 12.07% < 20% (prev 24.38%; Δ -12.32% < -1%) |
| CFO/TA 0.24 > 3% & CFO 1.08b > Net Income 613.4m |
| Net Debt (2.94b) to EBITDA (999.2m): 2.95 < 3 |
| Current Ratio: 1.42 > 1.5 & < 3 |
| Outstanding Shares: last quarter (254.1m) vs 12m ago -6.77% < -2% |
| Gross Margin: 72.80% > 18% (prev 0.72%; Δ 7.21k % > 0.5%) |
| Asset Turnover: 78.13% > 50% (prev 77.91%; Δ 0.22% > 0%) |
| Interest Coverage Ratio: 6.06 > 6 (EBITDA TTM 999.2m / Interest Expense TTM 147.6m) |
Altman Z'' -3.82
| A: 0.09 (Total Current Assets 1.43b - Total Current Liabilities 1.01b) / Total Assets 4.46b |
| B: -1.34 (Retained Earnings -5.97b / Total Assets 4.46b) |
| C: 0.20 (EBIT TTM 893.6m / Avg Total Assets 4.46b) |
| D: -1.36 (Book Value of Equity -6.39b / Total Liabilities 4.71b) |
| Altman-Z'' Score: -3.82 = D |
Beneish M -3.21
| DSRI: 0.93 (Receivables 303.5m/325.0m, Revenue 3.49b/3.48b) |
| GMI: 0.98 (GM 72.80% / 71.51%) |
| AQI: 1.00 (AQ_t 0.65 / AQ_t-1 0.65) |
| SGI: 1.00 (Revenue 3.49b / 3.48b) |
| TATA: -0.10 (NI 613.4m - CFO 1.08b) / TA 4.46b) |
| Beneish M-Score: -3.21 (Cap -4..+1) = AA |
What is the price of MTCH shares?
As of March 12, 2026, the stock is trading at USD 30.84 with a total of 4,009,604 shares traded.
Over the past week, the price has changed by -0.65%, over one month by -2.55%, over three months by -7.23% and over the past year by -0.13%.
Over the past week, the price has changed by -0.65%, over one month by -2.55%, over three months by -7.23% and over the past year by -0.13%.
Is MTCH a buy, sell or hold?
Match has received a consensus analysts rating of 3.57.
Therefor, it is recommend to hold MTCH.
- StrongBuy: 5
- Buy: 3
- Hold: 15
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the MTCH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 36.5 | 18.3% |
| Analysts Target Price | 36.5 | 18.3% |
MTCH Fundamental Data Overview March 10, 2026
P/E Trailing = 12.8025
P/E Forward = 8.9445
P/S = 2.106
P/B = 10.9696
P/EG = 0.3194
Revenue TTM = 3.49b USD
EBIT TTM = 893.6m USD
EBITDA TTM = 999.2m USD
Long Term Debt = 3.55b USD (from longTermDebt, last quarter)
Short Term Debt = 423.6m USD (from shortTermDebt, last quarter)
Debt = 3.97b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.94b USD (from netDebt column, last quarter)
Enterprise Value = 10.29b USD (7.34b + Debt 3.97b - CCE 1.03b)
Interest Coverage Ratio = 6.06 (Ebit TTM 893.6m / Interest Expense TTM 147.6m)
EV/FCF = 10.05x (Enterprise Value 10.29b / FCF TTM 1.02b)
FCF Yield = 9.95% (FCF TTM 1.02b / Enterprise Value 10.29b)
FCF Margin = 29.35% (FCF TTM 1.02b / Revenue TTM 3.49b)
Net Margin = 17.59% (Net Income TTM 613.4m / Revenue TTM 3.49b)
Gross Margin = 72.80% ((Revenue TTM 3.49b - Cost of Revenue TTM 948.4m) / Revenue TTM)
Gross Margin QoQ = 74.66% (prev 72.98%)
Tobins Q-Ratio = 2.31 (Enterprise Value 10.29b / Total Assets 4.46b)
Interest Expense / Debt = 1.09% (Interest Expense 43.1m / Debt 3.97b)
Taxrate = 17.69% (45.1m / 254.7m)
NOPAT = 735.5m (EBIT 893.6m * (1 - 17.69%))
Current Ratio = 1.42 (Total Current Assets 1.43b / Total Current Liabilities 1.01b)
Debt / Equity = -15.67 (negative equity) (Debt 3.97b / totalStockholderEquity, last quarter -253.5m)
Debt / EBITDA = 2.95 (Net Debt 2.94b / EBITDA 999.2m)
Debt / FCF = 2.88 (Net Debt 2.94b / FCF TTM 1.02b)
Total Stockholder Equity = -222.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 13.74% (Net Income 613.4m / Total Assets 4.46b)
RoE = -275.4% (negative equity) (Net Income TTM 613.4m / Total Stockholder Equity -222.8m)
RoCE = 26.86% (EBIT 893.6m / Capital Employed (Equity -222.8m + L.T.Debt 3.55b))
RoIC = 21.04% (NOPAT 735.5m / Invested Capital 3.50b)
WACC = 6.26% (E(7.34b)/V(11.32b) * Re(9.17%) + D(3.97b)/V(11.32b) * Rd(1.09%) * (1-Tc(0.18)))
Discount Rate = 9.17% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -6.11%
[DCF] Terminal Value 86.06% ; FCFF base≈967.0m ; Y1≈1.09b ; Y5≈1.47b
[DCF] Fair Price = 153.2 (EV 38.58b - Net Debt 2.94b = Equity 35.63b / Shares 232.6m; r=6.26% [WACC]; 5y FCF grow 14.93% → 2.90% )
EPS Correlation: 2.27 | EPS CAGR: 2.02% | SUE: 0.90 | # QB: 1
Revenue Correlation: 78.57 | Revenue CAGR: 2.56% | SUE: 1.45 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.87 | Chg7d=-0.062 | Chg30d=-0.062 | Revisions Net=+0 | Analysts=7
EPS current Year (2026-12-31): EPS=3.63 | Chg7d=-0.164 | Chg30d=-0.164 | Revisions Net=+0 | Growth EPS=+11.1% | Growth Revenue=+0.1%
EPS next Year (2027-12-31): EPS=4.03 | Chg7d=-0.100 | Chg30d=-0.100 | Revisions Net=+1 | Growth EPS=+11.1% | Growth Revenue=+4.2%
[Analyst] Revisions Ratio: +0.00 (2 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 1.4% (Discount Rate 9.2% - Earnings Yield 7.8%)
[Growth] Growth Spread = -1.8% (Analyst -0.5% - Implied 1.4%)
P/E Forward = 8.9445
P/S = 2.106
P/B = 10.9696
P/EG = 0.3194
Revenue TTM = 3.49b USD
EBIT TTM = 893.6m USD
EBITDA TTM = 999.2m USD
Long Term Debt = 3.55b USD (from longTermDebt, last quarter)
Short Term Debt = 423.6m USD (from shortTermDebt, last quarter)
Debt = 3.97b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.94b USD (from netDebt column, last quarter)
Enterprise Value = 10.29b USD (7.34b + Debt 3.97b - CCE 1.03b)
Interest Coverage Ratio = 6.06 (Ebit TTM 893.6m / Interest Expense TTM 147.6m)
EV/FCF = 10.05x (Enterprise Value 10.29b / FCF TTM 1.02b)
FCF Yield = 9.95% (FCF TTM 1.02b / Enterprise Value 10.29b)
FCF Margin = 29.35% (FCF TTM 1.02b / Revenue TTM 3.49b)
Net Margin = 17.59% (Net Income TTM 613.4m / Revenue TTM 3.49b)
Gross Margin = 72.80% ((Revenue TTM 3.49b - Cost of Revenue TTM 948.4m) / Revenue TTM)
Gross Margin QoQ = 74.66% (prev 72.98%)
Tobins Q-Ratio = 2.31 (Enterprise Value 10.29b / Total Assets 4.46b)
Interest Expense / Debt = 1.09% (Interest Expense 43.1m / Debt 3.97b)
Taxrate = 17.69% (45.1m / 254.7m)
NOPAT = 735.5m (EBIT 893.6m * (1 - 17.69%))
Current Ratio = 1.42 (Total Current Assets 1.43b / Total Current Liabilities 1.01b)
Debt / Equity = -15.67 (negative equity) (Debt 3.97b / totalStockholderEquity, last quarter -253.5m)
Debt / EBITDA = 2.95 (Net Debt 2.94b / EBITDA 999.2m)
Debt / FCF = 2.88 (Net Debt 2.94b / FCF TTM 1.02b)
Total Stockholder Equity = -222.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 13.74% (Net Income 613.4m / Total Assets 4.46b)
RoE = -275.4% (negative equity) (Net Income TTM 613.4m / Total Stockholder Equity -222.8m)
RoCE = 26.86% (EBIT 893.6m / Capital Employed (Equity -222.8m + L.T.Debt 3.55b))
RoIC = 21.04% (NOPAT 735.5m / Invested Capital 3.50b)
WACC = 6.26% (E(7.34b)/V(11.32b) * Re(9.17%) + D(3.97b)/V(11.32b) * Rd(1.09%) * (1-Tc(0.18)))
Discount Rate = 9.17% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -6.11%
[DCF] Terminal Value 86.06% ; FCFF base≈967.0m ; Y1≈1.09b ; Y5≈1.47b
[DCF] Fair Price = 153.2 (EV 38.58b - Net Debt 2.94b = Equity 35.63b / Shares 232.6m; r=6.26% [WACC]; 5y FCF grow 14.93% → 2.90% )
EPS Correlation: 2.27 | EPS CAGR: 2.02% | SUE: 0.90 | # QB: 1
Revenue Correlation: 78.57 | Revenue CAGR: 2.56% | SUE: 1.45 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.87 | Chg7d=-0.062 | Chg30d=-0.062 | Revisions Net=+0 | Analysts=7
EPS current Year (2026-12-31): EPS=3.63 | Chg7d=-0.164 | Chg30d=-0.164 | Revisions Net=+0 | Growth EPS=+11.1% | Growth Revenue=+0.1%
EPS next Year (2027-12-31): EPS=4.03 | Chg7d=-0.100 | Chg30d=-0.100 | Revisions Net=+1 | Growth EPS=+11.1% | Growth Revenue=+4.2%
[Analyst] Revisions Ratio: +0.00 (2 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 1.4% (Discount Rate 9.2% - Earnings Yield 7.8%)
[Growth] Growth Spread = -1.8% (Analyst -0.5% - Implied 1.4%)